It is our pleasure to welcome you to the 14th Annual T-Cell Lymphoma Forum. Presented in a hybrid format for 2022, you will have the option of attending live in La Jolla, CA, or virtually with the conference being live streamed.
Our exceptional faculty will present clinically relevant information that you will find immediately useful in the care of your patients. This three-day meeting provides interactive presentations, panel discussions and Q&A sessions.
The comprehensive agenda includes the most relevant topics that will deepen your understanding of these complex diseases and impact your care of patients today. At a glance, these will include:
- Epidemiology and Classification
- Molecular Biology and Pathogenesis
- T-Cell Lymphoma Subtypes
- Treatment
- Cutaneous T-Cell Lymphoma
- Novel Therapies on the PTCL Horizon
- Industry Innovations
As with any live conference, you will find additional opportunities to interact with your colleagues beyond the sessions. We invite you to explore the Poster Hall, network with your colleagues, and visit the Exhibit Hall.
Once again, we look forward to welcoming you to this important educational activity.
Sincerely,
Francine M. Foss, MD
Co-Chair
Professor of Medicine
Section of Medical Oncology
Yale University School of Medicine
Smilow Cancer Center
New Haven, CT
Won Seog Kim, MD, PhD
Co-Chair
Professor Division of Hematology/Oncology
Samsung Medical Center
Sungkyunkwan University
School of Medicine
Seoul, Republic of Korea
Owen A. O’Connor, MD, PhD
Co-Chair
American Cancer Society
Research Professor
Director, Program for T-cell Lymphoma
Department of Medicine
Division of Hematology and Oncology
University of Virginia Cancer Center
Charlottesville, VA
AGENDA
Select a session below to view more details.
